West Pharmaceutical Services Inc (WST)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 1,538,100 | 1,936,400 | 1,919,500 | 1,742,000 | 1,373,700 |
| Total current liabilities | US$ in thousands | 550,400 | 671,800 | 519,000 | 594,100 | 503,400 |
| Current ratio | 2.79 | 2.88 | 3.70 | 2.93 | 2.73 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $1,538,100K ÷ $550,400K
= 2.79
West Pharmaceutical Services Inc's current ratio has shown a generally positive trend over the past five years, increasing from 2.73 in December 31, 2020, to 2.79 in December 31, 2024. This indicates that the company is able to meet its short-term financial obligations comfortably, with increasingly stronger liquidity positions. However, there was a slight dip in the current ratio in December 31, 2023, which may warrant further investigation to assess the underlying factors. Overall, the current ratio values above 2 suggest that West Pharmaceutical Services Inc has a healthy liquidity position, with more than enough current assets to cover its current liabilities.
Peer comparison
Dec 31, 2024